Maples Group Advises ifeel on its US$20 Million Series B Investment Round
Maples and Calder (Ireland) LLP, the Maples Group’s law firm in Ireland, is pleased to have advised Ifeel – Humanising Growth (ifeel) on its US$20 million Series B investment round. Our Dublin based Corporate team was led by Partner, Jordan O’Brien, and supported by Associate, Emma Sheehy.
- Published
- in Deals
Ifeel is a leading European mental health solution for the enterprise and insurance world. The company combines advanced data analytics, clinical research, and state-of-the-art AI models to provide employers and insurers with the right tools to manage the mental health of employees and policyholders.
Jordan O’Brien commented: “We are delighted to have assisted ifeel on this milestone investment. Since their last investment round in 2022, the company has grown exponentially in part through the smart use of technology. As a law firm with extensive experience of partnering with innovation driven companies, we look forward to supporting the ifeel team on their growth journey. Many congratulations to Amir Kaplan, Martin Villanueva, Gabriele Murrone and the wider team at ifeel”.
Maples and Calder’s market leading global Corporate practice has experience as lead counsel for buyers, sellers, investors, issuers and acquisition targets across a range of sectors. In May 2024, the team advised Nory, the Irish AI-powered restaurant management system, on its US$16 million Series A funding round. The team also advised on some of the most high-profile acquisitions of Irish targets by global counterparties, such as the sale of Taoglas to Graham Partners, the sale of Version 1 to Partners Group, the sale of SteriPack to Inflexion, the sale of Taxamo to Vertex and the sale of Boxever to Sitecore.